North Carolina has added the Novavax vaccine to its arsenal of vaccines to help combat COVID-19.
Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.
Protein subunit vaccines work by injecting people with a tiny portion of a virus. In the case of the COVID-19 vaccine, that tiny portion is the spike protein that the coronavirus uses to enter cells.
The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.